Published ahead of print on December 23, 2004, doi:10.1164/rccm.200311-1535OC
Am. J. Respir. Crit. Care Med., Volume 171, Number 8, April 2005, 899-907
A more recent version of this article appeared on April 15, 2005
Submitted on November 12, 2003
Accepted on December 17, 2004
Characterization of Fibroblast Specific Protein 1 in Pulmonary Fibrosis
William E Lawson1, Vasiliy V Polosukhin2, Ornella Zoia2, Georgios T Stathopoulos2, Wei Han2, David Plieth3, James E Loyd2, Eric G Neilson4, and Timothy S Blackwell5*
1 Department of Medicine, Division of Allergy, Pulmonary and Critical Care Medicine, Vanderbilt University School of Medicine, Nashville, TN, USA; Department of Veterans Affairs Medical Center, Nashville, TN, USA,
2 Department of Medicine, Division of Allergy, Pulmonary and Critical Care Medicine, Vanderbilt University School of Medicine, Nashville, TN, USA,
3 Department of Medicine, Division of Nephrology, Vanderbilt University School of Medicine, Nashville, TN, USA,
4 Department of Medicine, Division of Nephrology, Vanderbilt University School of Medicine, Nashville, TN, USA; Department of Cell and Developmental Biology, Vanderbilt University School of Medicine, Nashville, TN, USA,
5 Department of Medicine, Division of Allergy, Pulmonary and Critical Care Medicine, Vanderbilt University School of Medicine, Nashville, TN, USA; Department of Veterans Affairs Medical Center, Nashville, TN, USA; Department of Cell and Developmental Biology, Vanderbilt University School of Medicine, Nashville, TN, USA
* To whom correspondence should be addressed. E-mail: timothy.blackwell{at}vanderbilt.edu.
Since fibroblasts produce collagen and other extracellular matrix components that are deposited during tissue fibrosis, defining the behavior of these cells is critical to understanding the pathogenesis of fibrotic diseases. We investigated the utility of fibroblast specific protein 1 (FSP1), a member of the calmodulin S100 troponin C superfamily, for identifying lung fibroblasts in a murine model of pulmonary fibrosis induced by intratracheal administration of bleomycin. Protein and mRNA expression of FSP1 was minimal in untreated lungs, but increased by 1 week following bleomycin administration and remained increased at 2 and 3 weeks after treatment. By immunohistochemistry, the number of FSP1+ cells increased in a dose dependent manner in the lungs following bleomycin treatment. Co-localization of 1 procollagen and FSP1 in interstitial cells demonstrated that FSP1+ fibroblasts contribute to the deposition of collagen following bleomycin administration. In primary lung cell cultures, lung fibroblasts, but not macrophages or type II alveolar epithelial cells, expressed FSP1. FSP1 also identified fibroblasts in lung biopsy specimens from patients with documented usual interstitial pneumonitis. Therefore, FSP1 is an improved marker for lung fibroblasts that could be useful for investigating the pathogenesis of pulmonary fibrosis.
Key words: lung, bleomycin, mouse, collagen, alpha smooth muscle actin
This article has been cited by other articles:

|
 |

|
 |
 
H. Tanjore, X. C. Xu, V. V. Polosukhin, A. L. Degryse, B. Li, W. Han, T. P. Sherrill, D. Plieth, E. G. Neilson, T. S. Blackwell, et al.
Contribution of Epithelial-derived Fibroblasts to Bleomycin-induced Lung Fibrosis
Am. J. Respir. Crit. Care Med.,
October 1, 2009;
180(7):
657 - 665.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Nakav, L. Kachko, M. Vorobiov, B. Rogachev, C. Chaimovitz, M. Zlotnik, and A. Douvdevani
Blocking adenosine A2A receptor reduces peritoneal fibrosis in two independent experimental models
Nephrol. Dial. Transplant.,
August 1, 2009;
24(8):
2392 - 2399.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Nasreen, K. A. Mohammed, K. K. Mubarak, M. A. Baz, O. A. Akindipe, S. Fernandez-Bussy, and V. B. Antony
Pleural mesothelial cell transformation into myofibroblasts and haptotactic migration in response to TGF-{beta}1 in vitro
Am J Physiol Lung Cell Mol Physiol,
July 1, 2009;
297(1):
L115 - L124.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Otsu, S. Das, S. D. Houser, S. K. Quadri, S. Bhattacharya, and J. Bhattacharya
Concentration-dependent inhibition of angiogenesis by mesenchymal stem cells
Blood,
April 30, 2009;
113(18):
4197 - 4205.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. T. Stathopoulos, I. Psallidas, A. Moustaki, C. Moschos, A. Kollintza, S. Karabela, I. Porfyridis, S. Vassiliou, M. Karatza, Z. Zhou, et al.
A Central Role for Tumor-derived Monocyte Chemoattractant Protein-1 in Malignant Pleural Effusion
J Natl Cancer Inst,
October 15, 2008;
100(20):
1464 - 1476.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Stevens, S. Phan, M. G. Frid, D. Alvarez, E. Herzog, and K. R. Stenmark
Lung Vascular Cell Heterogeneity: Endothelium, Smooth Muscle, and Fibroblasts
Proceedings of the ATS,
September 15, 2008;
5(7):
783 - 791.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. E. Lawson, P. F. Crossno, V. V. Polosukhin, J. Roldan, D.-S. Cheng, K. B. Lane, T. R. Blackwell, C. Xu, C. Markin, L. B. Ware, et al.
Endoplasmic reticulum stress in alveolar epithelial cells is prominent in IPF: association with altered surfactant protein processing and herpesvirus infection
Am J Physiol Lung Cell Mol Physiol,
June 1, 2008;
294(6):
L1119 - L1126.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. He, H. Kubo, K. Ishizawa, A. E. Hegab, Y. Yamamoto, H. Yamamoto, and M. Yamaya
The role of the receptor for advanced glycation end-products in lung fibrosis
Am J Physiol Lung Cell Mol Physiol,
December 1, 2007;
293(6):
L1427 - L1436.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Zhang, W. E. Lawson, V. V. Polosukhin, A. Pozzi, T. S. Blackwell, Y. Litingtung, and C. Chiang
Inhibitor of Differentiation 1 Promotes Endothelial Survival in a Bleomycin Model of Lung Injury in Mice
Am. J. Pathol.,
October 1, 2007;
171(4):
1113 - 1126.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Schneider, S. Kostin, C. C. Strom, M. Aplin, S. Lyngbaek, J. Theilade, M. Grigorian, C. B. Andersen, E. Lukanidin, J. Lerche Hansen, et al.
S100A4 is upregulated in injured myocardium and promotes growth and survival of cardiac myocytes
Cardiovasc Res,
July 1, 2007;
75(1):
40 - 50.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. J. Martinez and M. P. Keane
Update in diffuse parenchymal lung diseases 2005.
Am. J. Respir. Crit. Care Med.,
May 15, 2006;
173(10):
1066 - 1071.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. R. Stenmark, N. Davie, M. Frid, E. Gerasimovskaya, and M. Das
Role of the Adventitia in Pulmonary Vascular Remodeling
Physiology,
April 1, 2006;
21(2):
134 - 145.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. E. Lawson, V. V. Polosukhin, G. T. Stathopoulos, O. Zoia, W. Han, K. B. Lane, B. Li, E. F. Donnelly, G. E. Holburn, K. G. Lewis, et al.
Increased and Prolonged Pulmonary Fibrosis in Surfactant Protein C-Deficient Mice Following Intratracheal Bleomycin
Am. J. Pathol.,
November 1, 2005;
167(5):
1267 - 1277.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Q. Cheng, Y. Zhao, W. E. Lawson, V. V. Polosukhin, J. E. Johnson, T. S. Blackwell, and D. Gailani
The effects of intrinsic pathway protease deficiencies on plasminogen-deficient mice
Blood,
November 1, 2005;
106(9):
3055 - 3057.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2004 American Thoracic Society
|
|
|